The phenomenon of 'T cell exhaustion', a state of T cell dysfunction observed during chronic
infections and cancers, has been a major obstacle in mounting appropriate immune …

Background There is a concern that influenza vaccination may increase the incidence of
immune‐related adverse events in patients receiving immune checkpoint inhibitors (ICIs) …

2. Gargano SM, Senarathne W, Feldman R, et al. Novel therapeutic targets in salivary duct
carcinoma uncovered by comprehensive molecular profiling. Cancer Med. 2019; 8 …

The potential increased risk of immune-related adverse events (irAEs) post-influenza
vaccine is a concern in patients receiving immune checkpoint inhibitors (ICI). We conducted …

Methods: A systematic assessment of literature articles was performed by searching in
PubMed (MEDLINE), and major oncology meeting following PRISMA guidelines. Results …

In international guidelines, influenza vaccination is recommended to cancer patients
receiving antitumor treatment. Whether this recommendation should include patients treated …

The safety and efficacy of influenza vaccination is not well-studied in cancer patients
receiving immune checkpoint inhibitors (ICIs). A systematic review and meta-analysis was …

Influenza vaccination is recommended for advanced cancer patients, since impaired
immunity is presumed to be due not only to the tumor itself but also to immunosuppressive …

Objectives The emergence of immune checkpoint inhibitors has transformed treatment
paradigms for various malignancies. Patients with cancer are at increased risk of …

The use of immune checkpoint inhibitors (ICI) has substantially increased the overall
survival of cancer patients and has revolutionized the therapeutic situation in oncology …